<DOC>
	<DOCNO>NCT02042534</DOCNO>
	<brief_summary>Rationale Acute ischemic stroke due atrial fibrillation ( AF ) carry high risk early recurrence . In acute stage , guideline recommend aspirin , recommend anticoagulation due increase risk intracranial bleeding . Since , aspirin limited efficacy prevent recurrent stroke AF , expert consensus suggest early anticoagulation non-severe stroke AF . The current practice acute ischemic stroke patient AF delay warfarin administration aspirin use non-minor stroke immediate warfarin administration ( sometimes heparin bridge ) minor stroke . However , conventional anticoagulation warfarin acute ischemic stroke AF follow limitation : 1 ) risk intracranial bleed particularly acute stage , 2 ) delay action transient paradoxical thrombogenic tendency due inhibition protein C , result risk early recurrent embolic stroke , 3 ) prolongation hospitalization wait full anticoagulation . In contrast , compare warfarin , rivaroxaban advantageous reduce risk intracranial bleeding immediate anticoagulation efficacy . Goal The current trial examine whether early initiation ( within 5 day stroke onset ) rivaroxaban compare conventional warfarin would reduce intracranial bleeding , recurrent embolic stroke , hospital stay patient acute ischemic stroke due AF .</brief_summary>
	<brief_title>Rivaroxaban Versus Warfarin Acute Ischemic Stroke With Atrial Fibrillation</brief_title>
	<detailed_description>Primary endpoint : Composite MRI-defined intracranial bleeding recurrent ischemic lesion within 1 month randomization ( rivaroxaban v conventional warfarin )</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>All Acute ischemic stroke TIA presume cardioembolic origin ( within 5 day stroke onset ) mild severity : infarct size DWI le 1/3 MCA territory , 1/2 ACA territory , 1/2 PCA territory , 1/2 one cerebellar hemisphere Atrial fibrillation include paroxysmal atrial fibrillation : atrial fibrillation must document ECG evidence ( e.g. , 12lead ECG , rhythm strip , Holter , pacemaker interrogation ) within 30 day randomization . This could obtain notation subject 's record ( e.g. , medical chart , hospital discharge summary ) . Age ≥19 year Informed consent Any Chronic renal failure ( GFR less 30ml/min ) severe hepatic impairment Significant hemorrhagic transformation ( parenchymal hematoma type I II ECASS definition ) Stroke mechanism presume small vessel occlusion : single small subcortical infarct perforate artery territory Large hemispheric cerebellar infarction ; large 1/3 MCA territory , 1/2 ACA territory , 1/2 PCA territory , 1/2 one cerebellar hemisphere Mechanical valve require warfarin therapy Active internal bleeding Prior history symptomatic intracranial bleeding : patient asymptomatic bleeding microbleedings MRI eligible inclusion Major surgery major trauma within 30 day might associate increase bleed risk Clinically significant gastrointestinal bleeding within 6 month Intravenous tissue plasminogen activator use mechanical embolectomy within 48 hour plus 'significant hemorrhagic transformation describe ( exclusion criterion 2 ) ' 'large hemispheric infarction cerebellar infarction describe ( exclusion criterion 4 ) ' : patient achieve successful reperfusion without hemorrhage large infarction eligible enrollment Severe anemia : hemoglobin &lt; 10 g/dL Bleeding diathesis ; thrombocytopenia ( &lt; 90,000/µL , prolong PT ( INR &gt; 1.7 ) Sustained uncontrolled hypertension : SBP &gt; 180 mmHg DBP &gt; 100 mmHg Severe devastate illness , terminal cancer , hepatic failure ; therefore , participant life expectancy le 6 month . Planned invasive procedure potential uncontrolled bleeding , include major surgery</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>TIA</keyword>
</DOC>